ロード中...
Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production
A live-attenuated, human vaccine against mosquito-borne yellow fever virus has been available since the 1930s. The vaccine provides long-lasting immunity and consistent mass vaccination campaigns counter viral spread. However, traditional egg-based vaccine manufacturing requires about 12 months and...
保存先:
| 出版年: | Appl Microbiol Biotechnol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6153634/ https://ncbi.nlm.nih.gov/pubmed/30091043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00253-018-9275-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|